' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

Publikationen

Gewähltes Keyword: Specific immunotherapy


Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT.
Huber, S; Lang, R; Steiner, M; Aglas, L; Ferreira, F; Wallner, M; Hawranek, T; Gadermaier, G;
Clin Transl Allergy. 2018; 8: 39
Originalarbeiten (Zeitschrift)
Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.
Machado, Y; Duinkerken, S; Hoepflinger, V; Mayr, M; Korotchenko, E; Kurtaj, A; Pablos, I; Steiner, M; Stoecklinger, A; Lübbers, J; Schmid, M; Ritter, U; Scheiblhofer, S; Ablinger, M; Wally, V; Hochmann, S; Raninger, AM; Strunk, D; van Kooyk, Y; Thalhamer, J; Weiss, R;
J Control Release. 2017; 266: 87-99.
Originalarbeiten (Zeitschrift)
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases
Pfaar, O; Bachert, C; Bufe, A; Buhl, R; Ebner, C; Eng, P; Friedrichs, F; Fuchs, T; Hamelmann, E; Hartwig-Bade, D; Hering, T; Huttegger, I; Jung, K; Klimek, L; Kopp, MV; Merk, H; Rabe, U; Saloga, J; Schmid-Grendelmeier, P; Schuster, A; Schwerk, N; Sitter, H; Unnpfenbach, U; Wedi, B; Wohrl, S; Worm, M; Kleine-Tebbe, J; Kaul, S; Schwalfenberg, A
ALLERGOLOGIE. 2015; 38(9): 431-470.
Originalarbeiten (Zeitschrift)
Characterization of plant food allergens: an overview on physicochemical and immunological techniques.
Harrer, A; Egger, M; Gadermaier, G; Erler, A; Hauser, M; Ferreira, F; Himly, M;
Mol Nutr Food Res. 2010; 54(1): 93-112.
Übersichtsarbeiten
Specific immunotherapy (hyposensitization) for IgE-mediated allergic diseases
Kleine-Tebbe, J; Bufe, A; Ebner, C; Eigenmann, P; Friedrichs, F; Fuchs, T; Huttegger, I; Jung, K; Klimek, L; Kopp, M; Lassig, W; Merk, H; Niggemann, B; Rabe, U; Saloga, J; Schmid-Grendelmeier, P; Sitter, H; Virchow, JC; Wagenmann, M; Wedi, B; Worm, M; Hering, T; Koch, A; Lenders, H; Musken, H; Schnitzer, S; Stuck, BA; Voigtmann, I; Wehrmann, W; Kaul, S; Luther, B; Schwalfenberg, A
ALLERGOLOGIE. 2010; 33(1): 3-+.
Übersichtsarbeiten
Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening.
Thalhamer, T; Dobias, H; Stepanoska, T; Pröll, M; Stutz, H; Dissertori, O; Lackner, P; Ferreira, F; Wallner, M; Thalhamer, J; Hartl, A;
J Allergy Clin Immunol. 2010; 125(4):926-934.e10
Originalarbeiten (Zeitschrift)
Antigen aggregation decides the fate of the allergic immune response.
Zaborsky, N; Brunner, M; Wallner, M; Himly, M; Karl, T; Schwarzenbacher, R; Ferreira, F; Achatz, G
J IMMUNOL. 2010; 184(2): 72-35.
Originalarbeiten (Zeitschrift)
[Allergen-specific Immunotherapy for children and adolescents - a review on available products in Austria].
Szépfalusi, Z; Emminger, W; Eitelberger, F; Götz, M; Grillenberger, A; Horak, E; Huttegger, I; Koller, D; Litscher, H; Schmitzberger, R; Varga, EM; Riedler, J;
Wien Klin Wochenschr. 2009; 121(19-20):648-660
Übersichtsarbeiten
Characterization of HLA class II/peptide-TCR interactions of the immunodominant T cell epitope in Art v 1, the major mugwort pollen allergen.
Jahn-Schmid, B; Sirven, P; Leb, V; Pickl, WF; Fischer, GF; Gadermaier, G; Egger, M; Ebner, C; Ferreira, F; Maillere, B; Bohle, B;
J IMMUNOL. 2008; 181(5): 3636-3642.
Originalarbeiten (Zeitschrift)
Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapy.
Scheiblhofer, S; Stoecklinger, A; Gruber, C; Hauser-Kronberger, C; Alinger, B; Hammerl, P; Thalhamer, J; Weiss, R;
MOL IMMUNOL. 2007; 44(8): 1879-1887.
Originalarbeiten (Zeitschrift)
Optimization of codon usage is required for effective genetic immunization against Art v 1, the major allergen of mugwort pollen.
Bauer, R; Himly, M; Dedic, A; Ferreira, F; Thalhamer, J; Hartl, A;
Allergy. 2003; 58(10):1003-1010
Originalarbeiten (Zeitschrift)
Strategies for the development of safe and effective DNA vaccines for allergy treatment.
Hartl, A; Weiss, R; Hochreiter, R; Scheiblhofer, S; Bauer, R; Valenta, R; Ferreira, F; Leitner, W; Thalhamer, J;
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2003; 27-98
Übersichtsarbeiten
Genetic engineering of allergens: future therapeutic products.
Ferreira, F; Wallner, M; Breiteneder, H; Hartl, A; Thalhamer, J; Ebner, C;
Int Arch Allergy Immunol. 2002; 128(3): 171-178.
Übersichtsarbeiten
The influence of CpG motifs on a protein or DNA-based Th2-type immune response against major pollen allergens Bet v 1a, Phl p 2 and Escherichia coli-derived beta-galactosidase.
Hochreiter, R; Hartl, A; Freund, J; Valenta, R; Ferreira, F; Thalhamer, J;
Int Arch Allergy Immunol. 2001; 124(1-3): 406-410.
Originalarbeiten (Zeitschrift)
Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen.
Hartl, A; Kiesslich, J; Weiss, R; Bernhaupt, A; Mostböck, S; Scheiblhofer, S; Ebner, C; Ferreira, F; Thalhamer, J;
J Allergy Clin Immunol. 1999; 103(1 Pt 1):107-113
Originalarbeiten (Zeitschrift)
Isoforms of the major allergen of birch pollen induce different immune responses after genetic immunization.
Hartl, A; Kiesslich, J; Weiss, R; Bernhaupt, A; Mostböck, S; Scheiblhofer, S; Flöckner, H; Sippl, M; Ebner, C; Ferreira, F; Thalhamer, J;
Int Arch Allergy Immunol. 1999; 120(1):17-29
Originalarbeiten (Zeitschrift)
Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis.
Zenner, HP; Baumgarten, C; Rasp, G; Fuchs, T; Kunkel, G; Hauswald, B; Ring, J; Effendy, I; Behrendt, W; Frosch, PJ; Przybilla, B; Brunner, FX; Merk, HF; Kapp, A; Schnitker, J; Wolf, H;
J ALLERGY CLIN IMMUN. 1997; 100(1): 23-29.
Originalarbeiten (Zeitschrift)